ReviewBioscience reports2026
Bacterial pore-forming toxins: mechanisms and implications for host immunity.
Review in Bioscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gut microbiota-immune crosstalk in osteoarthritis: pathogenic mechanisms and emerging therapeutic opportunities.Frontiers in microbiology · 2026Review
- Oncolytic bacteria therapy for malignant glioma.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Pore-forming toxins (PFTs) are an ancient class of protein toxins specialized in membrane disruption and aiding in the pathogenicity of several different pathogens. These versatile toxins are multifunctional virulence factors that manipulate host signaling and immune responses and modulate the cellular fate. The pore-formation mechanism of PFTs proceeds in a stepwise manner, initiated by receptor binding, followed by oligomerization and membrane insertion. Beyond membrane disruption, PFTs trigger a cascade of immune signaling, inflammasome activation, and diverse cell death pathways such as apoptosis, pyroptosis, necroptosis, and ferroptosis. Additionally, there is increasing evidence suggesting that many PFTs undergo endocytosis and traffic to organelles such as mitochondria, lysosomes, the endoplasmic reticulum, and Golgi, where they modulate intracellular functions. Interestingly, some functions of PFTs are also independent of pore formation, highlighting the functional versatility of PFTs. Technological advancements ranging from cryo-electron microscopy and high-speed AFM to AI-guided modeling, single-molecule imaging, and membrane-mimetic systems have been central in providing structural and mechanistic insights into PFT biology. There has been the discovery of new toxins as well as new toxin families; many of them are antibacterial PFTs deployed in the microbial competition. The growing insights into PFT biology have opened new avenues for therapeutic innovation, both by developing strategies to neutralize PFT-mediated pathogenesis and by engineering PFTs for vaccine development and cancer treatment. In this review, we provide a comprehensive overview of PFT biology within the broader context of host-pathogen interactions and highlight the key structural, mechanistic, and cellular questions that remain unresolved.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.